The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin (DIACRON) - An Open-label Clinical Trial
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The objective of the trial is to investigate the effect of adherence to oral semaglutide dosing instructions on glycaemic control in people with type 2 diabetes, which are dysregulated on metformin and naïve to second line antidiabetic treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of type 2 diabetes for at least 1 year.
• HbA1c of 53-75 mmol/mol at ???.
• Treated with metformin for at least 1 year.
• Can understand and read Danish.
• Can use a smartphone, as well as the devices used in the clinical trial.
• Signed informed consent.
Locations
Other Locations
Denmark
Steno Diabetes Center North Denmark
RECRUITING
Aalborg
Contact Information
Primary
Nynne S Holdt-Caspersen, MSc
nynnesh@hst.aau.dk
00 45 61 65 92 60
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2025-03
Participants
Target number of participants: 20
Treatments
Study Cohort
People with dysregulated type 2 diabetes on metformin treatment, which are naïve to second line antidiabetic treatment. These participants will be started on oral semaglutide, as a second line antidiabetic treatment, in addition to their treatment with metformin. The participants will be started on 3mg and the dose increased according to the label. The oral semaglutide will be administered once daily.
Related Therapeutic Areas
Sponsors
Leads: Aalborg University Hospital